These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 7451917

  • 1. [First trimester termination of pregnancy. The value of treating the cervix pre-operatively in the primigravid patient by extra-amniotic administration of a single dose of F2-alpha prostaglandin gel (author's transl)].
    De Grandi P, Nguyen TH, Kunz B, Suppan P.
    J Gynecol Obstet Biol Reprod (Paris); 1980; 9(5):587-94. PubMed ID: 7451917
    [Abstract] [Full Text] [Related]

  • 2. [The induction of abortion and the priming of the cervix with prostaglandin F2 alpha and prostaglandin E2 by intra-amniotic, extra-amniotic and intra-cervical application (author's transl)].
    Schmidt W, Widmaier G, Ditz S, Kubli F.
    Geburtshilfe Frauenheilkd; 1982 Feb; 42(2):118-22. PubMed ID: 6917804
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Use of prostaglandin F2 alpha gel prior to termination of pregnancy of primigravidae for cervix maturation (author's transl)].
    Köhler G, Göretzlehner G, Lober R.
    Zentralbl Gynakol; 1981 Feb; 103(14):818-22. PubMed ID: 6945784
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Local application of prostaglandin F2 alpha to primigravid interruption patients in first trimester].
    Heinz M, Günther H, Pundrich C.
    Zentralbl Gynakol; 1982 Feb; 104(13):784-90. PubMed ID: 6958145
    [Abstract] [Full Text] [Related]

  • 10. [Cervical dilatation using PGF2 alpha gel before voluntary interruption of pregnancy during the first trimester].
    Maria B, Maghioracos P, Stragietti A, Prugnaud JL.
    J Gynecol Obstet Biol Reprod (Paris); 1983 Feb; 12(7):789-94. PubMed ID: 6668409
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Priming of the cervix at term with 3 methods: the oxytocin infusion, the administration of prostaglandin F2 alpha gel and the administration of prostaglandin E2 gel into the cervical canal (author's transl)].
    Schmidt W, Widmaier G, Arabin B, Ditz S, Kubli F.
    Geburtshilfe Frauenheilkd; 1982 Jan; 42(1):6-10. PubMed ID: 6916666
    [No Abstract] [Full Text] [Related]

  • 14. [Intracervical application of prostaglandin F2 alpha gel as low risk method of cervical dilatation for therapeutic abortion (author's transl)].
    Fritzsche H, Seewald HJ, Voigt R.
    Geburtshilfe Frauenheilkd; 1981 Mar; 41(3):237-8. PubMed ID: 7215769
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Cervical complications in the use of prostaglandin F2alpha (PGF2alpha) in pregnancy].
    Seifert B, Woraschk HJ.
    Zentralbl Gynakol; 1983 Mar; 105(4):208-11. PubMed ID: 6573824
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.